The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 137.50
Bid: 137.90
Ask: 138.00
Change: 1.45 (1.07%)
Spread: 0.10 (0.073%)
Open: 136.35
High: 138.55
Low: 136.35
Prev. Close: 136.05
CNA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

26 Mar 2024 15:25

RNS Number : 3809I
Centrica PLC
26 March 2024
 

Centrica plc (the "Company")

26 March 2024

Notification of Transactions of Directors

The Company announces the following transactions in respect of the Company's Ordinary Shares of 6 14/81 pence ("Shares") relating to Executive Directors.

The following notifications, made pursuant to Article 19 of the Market Abuse Regulation, provide further details.

Grant of Awards

Restricted Share Plan (RSP) awards of Shares were granted on 25 March 2024 to two Executive Directors.

The awards were granted under the terms of the Centrica Long Term Incentive Plan. 

Release of the RSP awards is subject to continued employment and the satisfaction of an underpin, assessed over the three-year period 2024 to 2026. In assessing the underpin, the Remuneration Committee will consider the Company's overall performance including financial and non-financial performance measures over the course of the vesting period, as well as any material risk or regulatory failures identified. Financial performance will include elements such as revenue, profitability, shareholder experience and return on capital. Non-financial performance will include a range of operational and strategic measures critical to the Company's long-term sustainable success. Post vesting, the Shares are subject to a mandatory additional two-year holding period.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name(s)

Chris O'Shea

2

Reason for the notification

a)

Position/status

Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Centrica plc

b)

LEI

E26EDV109X6EEPBKVH76

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

instrument, type of instrument

 

Identification code

Ordinary Shares of 6 14/81 pence

 

 

GB00B033F229

b)

Nature of the transaction

Grant of RSP Award under the Centrica Long Term Incentive Plan.

The number of Shares calculated by reference to a price of £1.2739, being the average of the Company's Share price over the five trading days immediately preceding the date of grant.

c)

Price(s) and volume(s)

 

Price

Volume

£1.2739

1,006,750

d)

Aggregated information

 

- Aggregated volume

- Price

 

 

 

1,006,750

£1,282,500

 

e)

Date of the transaction

25 March 2024

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name(s)

Russell O'Brien

2

Reason for the notification

a)

Position/status

Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Centrica plc

b)

LEI

E26EDV109X6EEPBKVH76

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

instrument, type of instrument

 

Identification code

Ordinary Shares of 6 14/81 pence

 

 

GB00B033F229

b)

Nature of the transaction

Grant of RSP Award under the Centrica Long Term Incentive Plan.

The number of Shares calculated by reference to a price of £1.2739, being the average of the Company's Share price over the five trading days immediately preceding the date of grant.

c)

Price(s) and volume(s)

 

Price

Volume

£1.2739

578,930

d)

Aggregated information

 

- Aggregated volume

- Price

 

 

 

578,930

£737,500

 

e)

Date of the transaction

25 March 2024

f)

Place of the transaction

Outside a trading venue

 

Acquisition of Shares

On 25 March 2024, Shares were acquired by Executive Directors as a result of the Annual Incentive Plan award relating to the 2023 financial year. The Shares are subject to a three-year holding period.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name(s)

Chris O'Shea

2

Reason for the notification

a)

Position/status

Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Centrica plc

b)

LEI

E26EDV109X6EEPBKVH76

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

instrument, type of instrument

 

Identification code

Ordinary Shares of 6 14/81 pence

 

 

 

GB00B033F229

b)

Nature of the transaction

Ordinary Shares acquired as a deferred award under the Annual Incentive Plan relating to the 2023 financial year.

c)

Price(s) and volume(s)

Price

Volume

£1.2686

562,135

d)

Aggregated information

 

- Aggregated volume

- Price

 

 

 

562,135

£713,125

 

e)

Date of the transaction

25 March 2024

f)

Place of the transaction

Outside a trading venue

 

Details of the person discharging managerial responsibilities/person closely associated

Name(s)

Russell O'Brien

Reason for the notification

Position/status

Executive Director

Initial notification/Amendment

Initial Notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Centrica plc

LEI

E26EDV109X6EEPBKVH76

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial

instrument, type of instrument

 

Identification code

Ordinary Shares of 6 14/81 pence

 

 

 

GB00B033F229

Nature of the transaction

Ordinary Shares acquired as a deferred award under the Annual Incentive Plan relating to the 2023 financial year.

Price(s) and volume(s)

Price

Volume

£1.2686

252,406

Aggregated information

 

- Aggregated volume

- Price

 

 

 

252,406

£320,203

 

Date of the transaction

25 March 2024

Place of the transaction

Outside a trading venue

 

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPUWPWUPCGCQ
Date   Source Headline
11th Apr 20236:25 pmRNSTransaction in Own Shares
6th Apr 20236:30 pmRNSTransaction in Own Shares
6th Apr 20234:30 pmRNSHolding(s) in Company
5th Apr 20236:30 pmRNSTransaction in Own Shares
5th Apr 20232:15 pmRNSHolding(s) in Company
5th Apr 20232:00 pmRNSTransfer of Treasury Shares
5th Apr 20237:00 amRNSCommencement of Share Buy-Back Programme
3rd Apr 202310:00 amRNSTotal Voting Rights
30th Mar 20235:30 pmRNSDirector/PDMR Shareholding
29th Mar 20236:25 pmRNSTransaction in Own Shares
28th Mar 20236:25 pmRNSTransaction in Own Shares
27th Mar 20236:20 pmRNSTransaction in Own Shares
27th Mar 202312:30 pmRNSDirector/PDMR Shareholding
24th Mar 20236:15 pmRNSTransaction in Own Shares
24th Mar 20235:00 pmRNSHolding(s) in Company
24th Mar 202310:00 amRNSHolding(s) in Company
23rd Mar 20236:00 pmRNSTransaction in Own Shares
22nd Mar 20236:10 pmRNSTransaction in Own Shares
22nd Mar 20233:30 pmRNSDirector/PDMR Shareholding
22nd Mar 202311:19 amRNSAnnual Financial Report 2022
21st Mar 20236:10 pmRNSTransaction in Own Shares
20th Mar 20236:20 pmRNSTransaction in Own Shares
20th Mar 20235:20 pmRNSHolding(s) in Company
17th Mar 20236:15 pmRNSTransaction in Own Shares
16th Mar 20236:00 pmRNSTransaction in Own Shares
16th Mar 20235:00 pmRNSHolding(s) in Company
15th Mar 20236:25 pmRNSTransaction in Own Shares
15th Mar 20234:20 pmRNSHolding(s) in Company
15th Mar 20239:00 amRNSDirector/PDMR Shareholding
14th Mar 20236:20 pmRNSTransaction in Own Shares
14th Mar 20237:00 amRNSPlans to extend life of two nuclear power stations
13th Mar 20236:25 pmRNSTransaction in Own Shares
13th Mar 20232:00 pmRNSDirector/PDMR Shareholding
10th Mar 20236:15 pmRNSTransaction in Own Shares
10th Mar 20233:45 pmRNSHolding(s) in Company
9th Mar 20236:15 pmRNSTransaction in Own Shares
8th Mar 20236:25 pmRNSTransaction in Own Shares
7th Mar 20236:25 pmRNSTransaction in Own Shares
6th Mar 20236:25 pmRNSTransaction in Own Shares
6th Mar 20234:20 pmRNSHolding(s) in Company
6th Mar 202312:50 pmRNSHolding(s) in Company
3rd Mar 20236:25 pmRNSTransaction in Own Shares
2nd Mar 20236:25 pmRNSTransaction in Own Shares
2nd Mar 20233:30 pmRNSHolding(s) in Company
1st Mar 20236:34 pmRNSTransaction in Own Shares
1st Mar 20234:45 pmRNSTotal Voting Rights
28th Feb 20236:15 pmRNSTransaction in Own Shares
28th Feb 202312:15 pmRNSHolding(s) in Company
27th Feb 20236:25 pmRNSTransaction in Own Shares
27th Feb 202312:45 pmRNSCommittee Chair Succession & Director Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.